JHS Svendgaard

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

JHS Svendgaard - overview

Established

1997

Location

New Delhi, -, India

Primary Industry

Healthcare Specialists

About

JHS Svendgaard Laboratories Limited specializes in manufacturing a diverse range of oral and personal care products, including toothbrushes, toothpaste, and mouthwash, focusing on quality and effective hygiene solutions for consumers. Founded in 1997 and headquartered in New Delhi, India, JHS Svendgaard Laboratories Limited operates primarily in the oral and personal care sector. The company has expanded its product offerings from toothbrushes to a complete range of oral hygiene items and partners with major retailers for private label products. It has successfully completed 4 deals, with its most recent funding round being a PIPE amounting to INR 33.


00 mn, raising the total funds to INR 33. 00 mn. The firm is targeted by investors such as Sixth Sense Ventures. JHS Svendgaard Laboratories Limited is engaged in manufacturing a comprehensive selection of oral care and personal care products, including toothbrushes, toothpaste, mouthwash, and denture tablets.


Starting with a focus on toothbrushes, the company has broadened its product line to meet the growing demand for effective dental solutions. JHS serves a wide variety of clients, including domestic and international brands, and collaborates with major retailers such as Walmart and Boots on private label products. Its offerings extend into various geographical markets, showcasing the company's commitment to enhancing consumer health through a diversified FMCG product range. In 2023, JHS Svendgaard Laboratories Limited reported a revenue of INR 10,206,615.


50 and achieved an EBITDA of INR 852,393. 60 in 2022. The company generates revenue through B2B partnerships and manufacturing contracts with significant players in the consumer goods sector, facilitating the distribution of its products directly to retailers or through private label agreements. Looking ahead, JHS Svendgaard Laboratories Limited plans to continue its expansion into new geographical markets, although specific regions and timelines have not been disclosed.


The recent PIPE funding round of INR 33. 00 mn will aid the company in pursuing new product developments and enhancing its manufacturing capabilities. Additionally, the firm aims to exit through the stock exchange, further solidifying its position in the market.


Current Investors

Tano Capital

Primary Industry

Healthcare Specialists

Sub Industries

Dental Products & Services

Website

www.svendgaard.com

Verticals

Manufacturing

Company Stage

Mature

Total Amount Raised

Subscriber access only

JHS Svendgaard - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Private Placement/Follow onCompletedJHS Svendgaard-
PIPECompletedJHS Svendgaard-
PIPECompletedJHS Svendgaard-
Private Placement/Follow onCompletedJHS Svendgaard-

Displaying 1 - 4 of 4

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.